1-9 of 9
Ralf Schmidmaier
Close
Sort by
Journal Articles

The Novel Pan-HDAC Inhibitor CR2408 Inhibits Multiple Myeloma Cell Growth and Proliferation

Philipp Baumann, Carmen Junghanns, Strobl Stefan, Fuat Oduncu, Ralf Schmidmaier
Journal: Blood
Blood (2011) 118 (21): 5133.
https://doi.org/10.1182/blood.V118.21.5133.5133
Published: 2011
Journal Articles

The Novel Histone Deacetylase Inhibitor RAS2410 (Resminostat) Interferes with Important Signalling Pathways and Induces Apoptosis in Multiple Myeloma Cells.

Philipp Baumann, Sonja Mandl-Weber, Felix Meinel, Ruediger Jankowsky, Fuat S. Oduncu, Ralf Schmidmaier
Journal: Blood
Blood (2009) 114 (22): 4928.
https://doi.org/10.1182/blood.V114.22.4928.4928
Published: 2009
Journal Articles

Phase I/II Study with Single Agent Everolimus (RAD001) in Patients with Relapsed or Refractory Multiple myeloma.

Andreas Guenther, Philipp Baumann, Renate Burger, Wolfram Klapper, Ralf Schmidmaier, Martin Gramatzki
Journal: Blood
Blood (2009) 114 (22): 3850.
https://doi.org/10.1182/blood.V114.22.3850.3850
Published: 2009
Journal Articles

The Novel NFkB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma Cells and Overcomes NFkB Mediated Drug Resistance.

Felix Meinel, Sonja Mandl-Weber, Philipp Baumann, Johann Leban, Ralf Schmidmaier
Journal: Blood
Blood (2008) 112 (11): 1715.
https://doi.org/10.1182/blood.V112.11.1715.1715
Published: 2008
Journal Articles

S-2209, a Novel, Non-Boronic Proteasome Inhibitor, Induces Apoptosis and Cell Growth Arrest in Multiple Myeloma Cells.

Philipp Baumann, Karin Mueller, Sonja Mandl-Weber, Helmut Ostermann, Ralf Schmidmaier, Fuat Oduncu, Johann Leban, Robert Doblhofer, Astrid Ammendola, Roland Baumgartner
Journal: Blood
Blood (2007) 110 (11): 1513.
https://doi.org/10.1182/blood.V110.11.1513.1513
Published: 2007
Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Christian Straka, MD, PhD, Peter Liebisch, MD, Burkhard Hennemann, MD, Bernd Metzner, MD, Hans Salwender, MD, Lothar Kanz, MD, PhD, Sigrid Adler-Reichel, MD, Wolf-Dieter Ludwig, MD, PhD, Hannes Wandt, MD, PhD, Martin Bentz, MD, PhD, Tim Bruemmendorf, MD, PhD, Markus Hentrich, MD, Lorenz Truemper, MD, PhD, Mathias Freund, MD, PhD, Hans-Heinrich Wolf, MD, Sezer Orhan, MD, PhD, Ralf Bargou, MD, PhD, Gottfried Doelken, MD, PhD, Norbert Schmitz, MD, PhD, Helga Bernhard, MD, PhD, Martin Gramatzki, MD, PhD, Norbert Frickhofen, MD, PhD, Helmut Ostermann, MD, PhD, Ralf Schmidmaier, MD, Stefan Ibach, PhD, Axel Hinke, PhD, Hermann Einsele, MD, PhD, Bertold Emmerich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 446.
https://doi.org/10.1182/blood.V110.11.446.446
Published: 2007
Journal Articles

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Philipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, Christian Straka, Daniel Franke, Ralf Schmidmaier
Journal: Blood
Blood (2006) 108 (11): 5045.
https://doi.org/10.1182/blood.V108.11.5045.5045
Published: 2006
Journal Articles

Higher Expression Levels of the Adhesion Molecules VLA-4 and ICAM-1 on Multiple Myeloma Cells after Chemotherapy Are Associated with Survival of a Multidrug Resistant Subpopulation in Vivo.

Ralf Schmidmaier, MD, Kerstin Mörsdorf, Philipp Baumann, Bertold Emmerich, MD, Gerold Meinhardt, MD
Journal: Blood
Blood (2004) 104 (11): 4866.
https://doi.org/10.1182/blood.V104.11.4866.4866
Published: 2004
Journal Articles

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Ralf Schmidmaier, Philipp Baumann, Meral Simsek, Farshid Dayyani, Bertold Emmerich, Gerold Meinhardt
Journal: Blood
Blood (2004) 104 (6): 1825–1832.
https://doi.org/10.1182/blood-2003-12-4218
Published: 2004